AZITHROMYCIN
Stephen Josh V. Lim BSN 3A
Generic Name     AZITHROMYCIN
Brand Name       Zithromax, Zmax
Classification   ANTIINFECTIVE; MACROLIDE ANTIBIOTIC
General Action   A macrolide antibiotic that reversibly binds to the 50S ribosomal subunit of
                 susceptible organisms and consequently inhibits protein synthesis.
Dose and Route   Bacterial Infections
                 Adult: PO 500 mg on day 1, then 250 mg q24h for 4 more d IV 500 mg
                 q.d. for at least 2 d, administer 1 mg/mL over 3 h or 2 mg/mL over 1 h
                 Child: PO 6 mo, 10 mg/kg on day 1, then 5 mg/kg for 4 more d (max:
                 250 mg/d)
                 Acute Bacterial Sinusitis
                 Adult: PO 500 mg once daily x 3 d. Zmax: single one-time dose of 2 g.
                 Child: PO 6 mo, 10 mg/kg once daily x 3 d
                 Otitis Media
                 Child: PO >6 mo, 30 mg/kg as a single dose or 10 mg/kg once daily (not to
                 exceed 500 mg/d) for 3 d or 10 mg/kg as a single dose on day 1 followed
                 by 5 mg/kg/d on days 2–5
                 Gonorrhea
                 Adult: PO 2 g as a single dose
                 Chancroid
                 Adult: PO 1 g as a single dose
                 Child: PO 20 mg/kg as single dose (max: 1 g)
Indications or      Pneumonia, lower respiratory tract infections, pharyngitis/tonsillitis,
Purposes            gonorrhea, nongonococcal urethritis, skin and skin structure infections due
                    to susceptible organisms, otitis media, Mycobacterium avium–
                    intracellulare complex infections, acute bacterial sinusitis. Zmax: acute
                    bacterial sinusitis and community acquired pneumonia.
Side effects         CNS: Headache, dizziness.
                    GI: Nausea, vomiting, diarrhea, abdominal pain; hepatotoxicity, mild
                    elevations in liver function tests.
Contraindications   Hypersensitivity to azithromycin, erythromycin, or any of the macrolide
                    antibiotics.
Nursing             Assessment & Drug Effects
Responsibilities
                          Monitor for and report loose stools or diarrhea, since
                           pseudomembranous colitis (see Appendix F) must be ruled out.
                          Monitor PT and INR closely with concurrent warfarin use.
                    Patient & Family Education
                          Direct sunlight (UV) exposure should be minimized during therapy
                           with drug.
                          Take aluminum or magnesium antacids 2 h before or after drug.
                          Report onset of loose stools or diarrhea.
                          Do not breast feed while taking this drug without consulting
                           physician.